The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Aliev S.A.

Azerbaijan Medical University

Mamedova S.Yu.

Azerbaijan Medical University

Aliev É.S.

Azerbaijan Medical University

Endoscopic intragastric injection of botulinum toxin in the treatment of patients with morbid obesity: opportunities and prospects

Authors:

Aliev S.A., Mamedova S.Yu., Aliev É.S.

More about the authors

Journal: Pirogov Russian Journal of Surgery. 2023;(1): 81‑88

DOI: 10.17116/hirurgia202301181

Read: 2382 times

Download PDF (RU)
Contact the author
Table of contents

ENDOSCOPIC INTRAGASTRIC INJECTION OF BOTULINUM TOXIN IN THE TREATMENT OF PATIENTS WITH MORBID OBESITY: OPPORTUNITIES AND PROSPECTS
ENDOSCOPIC INTRAGASTRIC INJECTION OF BOTULINUM TOXIN IN THE TREATMENT OF PATIENTS WITH MORBID OBESITY: OPPORTUNITIES AND PROSPECTS

To cite this article:

Aliev SA, Mamedova SYu, Aliev ÉS. Endoscopic intragastric injection of botulinum toxin in the treatment of patients with morbid obesity: opportunities and prospects. Pirogov Russian Journal of Surgery. 2023;(1):81‑88. (In Russ.)
https://doi.org/10.17116/hirurgia202301181

Подписка 2026 Хирургия. Журнал им. Н.И. Пирогова (Pirogov Russian Journal of Surgery)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Options for the surgical technique of lapa­roscopic sleeve gastrectomy for prevention and treatment of gastroesophageal reflux in patients with obesity. Endo­scopic Surgery. 2024;(6):57-68
Safety asse­ssment of bariatric surgery in the Russian Fede­ration acco­rding to the Russian National Bariatric Regi­stry. Endo­scopic Surgery. 2025;(1):5-14
Meta­bolic syndrome and anti­psychotic therapy of schi­zophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):165-170
Problems of regu­lar medi­cal check-up orga­nization of young males aged 15—17 years with cardiometabolic diseases. Russian Journal of Preventive Medi­cine. 2024;(12):81-87
Application of modern methods for acti­vation of brain functions in obese patients (literature review). Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(6):54-61
Pote­ntial applications of botu­linum toxin formulations in addressing postnasal syndrome. Russian Rhinology. 2024;(4):301-307
Comparative analysis of the state of the microvasculature of the oral mucosa in persons with meta­bolic syndrome in the aspect of orthopedic dental reha­bilitation. Stomatology. 2024;(6-2):15-22
Rela­tionship between meta­bolic syndrome components and pathology of the red border of the lips and oral mucosa. Russian Journal of Operative Surgery and Clinical Anatomy. 2024;(4-2):58-63
Changes in muscle tone after electrotherapy in patients suffering from chro­nic migraine and cervicalgia. Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(6-2):96-101
Choosing the opti­mal surgical method for duodenal ulcer complicated by bleeding. Piro­gov Russian Journal of Surgery. 2025;(2):111-118
Abstract:

The authors consider modern epidemiological and demographic data on morbid obesity. Literature review is devoted to non-surgical treatment of patients with morbid obesity. The authors analyze the results of experimental and clinical studies on endoscopic intragastric injection of botulinum toxin and bariatric efficacy of this approach. The indications for endoscopic intragastric injection of botulinum toxin and advantages of this technique are clearly formulated. The authors identified the most significant criteria for objective assessment of clinical effectiveness of endoscopic intragastral injection of botulinum toxin, as well as scientific and methodological principles necessary for this technique. Clinical efficacy of intragastric injection of botulinum toxin including overweight loss, anorexigenic and gastroparetic effects indicates inconsistent results and certain unresolved problems. Thus, large-scale multiple-center randomized controlled trials and multivariate analysis are required to determine the role of endoscopic intragastric injection of botulinum toxin in complex treatment of patients with morbid obesity.

Keywords:

morbid obesity
methabolic syndrome
bariatric surgery
botulinum toxin
intragastric injection

Authors:

Aliev S.A.

Azerbaijan Medical University

Mamedova S.Yu.

Azerbaijan Medical University

Aliev É.S.

Azerbaijan Medical University

Received:

01.05.2022

Accepted:

14.07.2022

Close metadata

References:

  1. Pinhas-Hamiel O, Hamiel U, Bendor CD, Bardugo A, Twig G, Cukierman-Yaffe F. The global spread of severe obesity is toddlers, children, and adolescents: A systematic review and meta-analysis. Obesity Facts. 2022;15:118-134.  https://doi.org/10.1159/000521913
  2. https://www.euro.who.int/InformationSources/Publications/Catalogue/20070220_1?Ianguage= Russian https://www.euro.who.int/InformationSources/Publications/Catalogue/20070220_1?English=English
  3. Nikoletta Vidra, Sergi Trias-Llimas, Fanny Janssen. Impact of obesity on life expectancy among different European countres: secondary analysis of population-level data over the 1975—2012 period. BMI Open. 2019;9(7):e028086.
  4. Joseph M, Kapoor N, Ramasamy S, Jiwanmall S, Kattula D, Abraham V, Sama-rasam I, Paul T, Thomas N. Nutritional profile of morbidly obese patients at-tending a bariatric clinic in a South Indian tertiary care centre. Obesity and meta-bolism. 2017;14(2):41-47.  https://doi.org/10.14341/omet2017241-47
  5. Schoeller D. The challenge of obesity in the WHO European Region and Strategies of Response. Medicine and Sciene in sports and exer-cise. 2008;40(3):590.  https://doi.org/10.1249/mss.0b013e318164f33c
  6. Di Cesare M, Bentham J, Stevens GA, Zhou B, Danaei G, Lu Y, Bixby H, Cowan MJ, Riley LM, Hajifathalian K, Fortunato L, et al. Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19,2 million participants. Lancet. 2016;387(10026):1377-1396. https://doi.org/10.1016/s0140-6736(16)30054-x
  7. Abarca-Gomez L. (NCD Risk Factor Collaboration). Worldwide trends in body-mass index, underweight, overweight, and obesty from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128,9 million children, adolescents, and adults. The Lancet. 2017;390(10113):2627-2642. https://doi.org/10.1016/s0140-6736(17)32129-3
  8. Atilla Engin. The definition and prevalenceof obesity and metabolic syndrome. Adv Exp Med Biol. 2017;960:1-17.  https://doi.org/10.1007/978-3-319-48382-5_1
  9. Kinlen D, Cody D, O Shea D. Complications of obesity. QJM: An International Journal of Medicine. 2018:111(7):437-443.  https://doi.org/10.1093/qjmed/hcx152
  10. Leitner DR, Frübeck G, Yumuk V, Schindler K, Micic D, Woodward E, Toplak H. Obesity and type2 diabetes: two diseases with a need for combined treatment strategies-EASO can lead the way. Obesty Facts. 2017;10:483-492.  https://doi.org/10.1159/000480525
  11. Toplak H, Hoppichler F, Wascher TC, Schindler K, Ludvik B. Obesity and type 2 diabetes (in German). Wien Klin Wochenschr. 2016;128(2):96-200.  https://doi.org/10.1007/s00508-016-0986-9
  12. Obesity management for the treatment of type 2 diabetes. American Diabetes Association. 2016;39:47-51.  https://doi.org/10.2337/dc16-s009
  13. Gefalu TW, Bray GA, Home Ph D, Garvey WT, Klein S, Pi-Sunyer FX, Hu FB, Raz I, et al. Advances in the science, treatment and prevention of the Disease of Obesity: reflections from a Diabetes Care Editors Expert Forum. Diabetes Care. 2015;38(8):1567-1582. https://doi.org/10.2337/dc15-1081
  14. Bradshow PT, Monda KL, Stevens J. Metabolic syndrome in healthy obese, overweight and normal weight individuals: the atherosclerosis risk in communities study. Obesity (Silver Spring). 2013;21(1):203-209.  https://doi.org/10.1002/oby.20248
  15. Verbovoy AF, Passhentseva AV, Sharonova LA. Obesity and cardiovascular system. Klin med. 2017;95(1):31-35. (In Russ.). https://doi.org/10.18821/0023-2149-2017-95-1-31-35
  16. Bohula EA, Scirica BM, Fanola C, Inzucchi SE, Keech A, Mc Guire DK, et al. Design and rationale for the cardiovascular and metabolic effects of lorcaserin in overweight and obese patients-thrombolysis in myocardial infarction 61(CAMELLIA-TIMI 61) trial. Am heart J. 2018;202:39-48. 
  17. Nakamura K, Fuster JJ, Walsh K. Adipkines: a link betwen obesity and cardiovascular disease. J Cardiol. 2014;63:250-259.  https://doi.org/10.1016/j.jjcc.2013.11.006
  18. Chondronikola M, Harris LL, Klein S. Bariatric surgery and type2 diabetes: are there wight loss-independent therapeutic effects of upper gastrointestinal bypass? J Intern Med. 2016;280:476-486.  https://doi.org/10.1111/joim.12527
  19. Koliaki Ch, Liatis S, Le Roux CW, Kokkinos A. The role of bariatric surgery to treat diabetes: current challenges and perspective. BMC Endocrine Disordes. 2017;17(1):50.  https://doi.org/10.1186/s12902-017-0202-6
  20. Praven Raj P, Bhattacharya S, Saravana Kumar S, Sabnis SC, Parthasathi R, Swamy PDK, Palanivelu C. Do bariatric surgery-related type2 diabetes remission predictors and clinical value? A study on Asian Indian Obese Diabetics Obes Surg. 2017;27(8):2113-2119. https://doi.org/10.1007/s11695-017-2615-8
  21. Kassem MAA, Durda MA, Stoicea N, Cavus O, Sahin L, Rogers B. The impact bariatric surgery on type 2 diabetes mellitus and the management of hypoglycemic events. Front Endocrinol (Laussanne) 2017;8:37.  https://doi.org/10.3389/fendo.2017.00037
  22. Cercato C, Fonseca FA. Cardiovascular risk and obesity. Diabetology and metabolic syndrome. 2019;11(79):2-15.  https://doi.org/10.1186/s13098-019-0468-0
  23. Thourani VH, Keeling WB, Kilgo PD, Puskas JD, Lattouf OM, Chen EP, Guyton RA. The impact of body mass index on morbidity and short and long-term mortality in cardiac valvular surgery. J Thorac Cardiovasc Surg. 2011;142:1052-1061. https://doi.org/10.1016/j.jtcvs.2011.02.009
  24. Guffey CR, Fan D, Singh UP, Murphy EA. Linking obesity to colorectal can-cer: recent insights into plansible biological mechanisms. Curr Opin Nutr Metab Care. 2013;16(5):595-600.  https://doi.org/10.1097/MCO.0b013e328362d10b
  25. Di Angelantonio E, Bhupathiraju S, Wormser D, Gao P, Kaptoge S, De Gonzalez AB, Cairns B, Huxley R, Jackson Ch, et al. Body-mass indez and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. The Global BMI Mortality Collaboration. The Lancet. 2016;388(10046):776-786.  https://doi.org/10.1016/s0140-6736(16)30175-1
  26. Oslopov VN, Bogayavlenskaja OV. The body shape index is a new indicator of the risk of premature death. Kazan medical journal. 2015;96(2):253-256. (In Russ.). https://doi.org/10.17750/KMJ2015-253
  27. Johnson AP, Parlov JL, Whitehead M, Xu L, Rohland S, Milne B. Body mass index, outcomes, and mortality following cardiac surgery in Ontario. Canada J Am Heart Assoc. 2015;4:e00240. https://doi.org/10.1161/JAHA.115.002140
  28. Dedov İİ, Melnichenko GA, Shesta-kova MV, Troshina EA, Mazurina NV, Shestakov EA, Yashkov YuU, Neimark AE, et al. Russian national clinical recommendations for morbid obesity treatment in adults. 3-rd revision (Morbid obesity treatment in adults). Obesity and metabolism. 2018;15(1):53-70. (In Russ.). https://doi.org/10.14341/omet2018153-70
  29. Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Manni G, et al. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomized controlled trial. Lancet. 2015;386:964-973.  https://doi.org/10.1016/s0140-6736(15)00075-6
  30. Tang Q, Sun Z, Zhang N, Xu G, Song P, Xu L, et al. Cost-effectiveness of bariatric surgery for type 2 diabetes mellitus: a randomized controllsd trial in China. Medicine (Baltimore). 2016;95:e3522. https://doi.org/10.1097/MD.0000000000003522
  31. Norbert Runkel, Rainer Brydniak Surgical treatment of metabolic syndrome. Visk Med. 2016:32(5):352-356.  https://doi.org/10.1159/000449110
  32. Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Aminian A, Brethauer SA, et al. Bariatric surgery versus intenssive medical therapy for diabetes-5 year outcomes. N Engl J Med. 2017;376:641-651.  https://doi.org/10.1056/NEJMoa1600869
  33. Lemus R, Karni D, Hong D, Gmora S, Breau R, Anvari M. Theimpact of bariatric surgery on insulin-treated type2 diabetes patients. Surg Endosc. 2018;32:990-1001. https://doi.org/10.1007/s00464-017-5777-5
  34. Alsumali A, Eguale T, Bairdain S, Samnaliev M. Cost-effectiveness analysis of bariatric surgery for morbid obesity. Obes Surg. 2018;28:2203-2214. https://doi.org/10.1007/s11695-017-3100-0
  35. Viratanapanu I, Romyen C, Chaivanijchaya K, Sornphiphatphong S, Kattipatanapong W, Techagumpuch A, et al. Effectiveness evaluation of bariatric surgery for morbidy obese with diabetes patients in Thailand. J Obes. 2019;2019:5383478-6.  https://doi.org/10.1155/2019/5383478
  36. Diamentis Th, Apostolon KG, Alexandron A, Griniatsos J, Tsigris Ch. Review of long-term weight loss results after laparoscopic sleeve gastrectomy. Surg Obes Relat Dis. 2014;10(1):177-183.  https://doi.org/10.1016/j.soard.2013.11.007
  37. Antanavicius G, Rezvani M, Sucandy I. One-stage roboticallyassisted laparoscopic biliopancreatic diversion with duodenal with: analysis of 179 ptients. Surg Obes Relat Dis. 2015;11(20):367-371.  https://doi.org/10.1016/j.soard.2014.10.023
  38. Hirth DA, Jones EL, Rothchild KB, Mitchell BC, Schoen JA. Laparoscopic sleeve gastrectomy: long-term weight loss outcomes. Surg Obes Relat Dis. 2015;11:1004-1007. https://doi.org/10.1016/j.soard.2015.02.016
  39. Angrisani L, Santonicola A, Hasani A, Nosso G, Capaldo B. Iovino: five — year results of laparoscopic sleeve gastrectomy: effects on gastroesophageal reflux disease symptoms and co-morbidities. Surg Obes Relat Dis. 2016;12:960-968.  https://doi.org/10.1016/j.soard.2015.09.014
  40. Felsenreich DM, Langer FB, Kefurt R, Attit Baskota. Weight loss, weight regain and conversions to Roux-en-Y gastric bypass-10-year result of laparoscopic sleeve gastrectomy. Surg Obes Relat Dis. 2016;12:1651-1654. https://doi.org/10.1016/j.soard.2016.02.021
  41. Li J, Lai D,Wu D. Laparoscopic Roux-en-Y-gastric bypass vs laparoscopic sleeve-gastrectomy to treat morbid obesity- related comorbidis: a systematic review and meta-analysis. Obes Surg. 2016;26(2):429-442.  https://doi.org/10.1007/s11695-015-1996-9
  42. Ejaz A, Patel P, Gonzalez-Heredia R, et al. Laparoscopic sleeve gatrectomy as first-line surgical treatment for morbid obesity among adolescents. J Pediatr Surg. 2017;52:544-548.  https://doi.org/10.1016/j.jpedsurg.2016.08.023
  43. Franco RR, Ybarra M, Cominato L, MattarL, Steinmetz L, Damiani D, Carlos M, Velhote P. Laparoscopic sleeve- gastrectomy in severely obese adolescents: effects on metabolic profile. Arch Endocrinol Metab. 2017;61:608-613.  https://doi.org/10.1590/2359-3997000000310
  44. Fishman MB, Van Yan, Sokolova DA. Possible reasons of insufficient efficacy of laparoscopic gastric bypass in surgical treatment of metabolic. Vestnik khirurgii. 2017;176:43-49. (In Russ.).
  45. Koprovski RM, Weston AC, Schmid H. Evaluation of metabolic syndrome in morbidy obese patients submitted to laparoscopic bariatric surgery: comparison of the results between Roux-En-Y gastric bypass and sleeve gastrectomy. Obes Surg. 2017:27(7):1719-1723. https://doi.org/10.1007/s11695-017-2547-3
  46. Capaescu C. Laparoscopic biliopancreatic diversion with duodenal switch-the most effective operation for type 2 diabetes mellitus. HowI doit? Chirurgia (Bucur). 2018;113(5):704-711.  https://doi.org/10.21614/chirurgia.113.5.704
  47. Peterli R, Wolnerhanssen BK, Peters Th. Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss in patients with morbid obesity. The SM-BOSS randomized clinical trial. JAMA. 2018;319(2):255-265.  https://doi.org/10.1001/jama.2017.20897
  48. Harsha V, Pankaj J. Pasricha. Botulinum Toxin for Gastrointestinal Disorders. Therapy and Mechanisms June 2006 Neurotoxicity Research; 9:149-159.  https://doi.org/10.1007/BF03033934
  49. Lee JH, Kim CG, Kim YW, Choi IJ, Lee JY, Cho SJ, Kim YI, Eom BW, Yoon HM, Ryu KW. Botulinum Toxin Injection for the Treatment of Delayed Gastric Emptying Following Pylorus-Preserving Gastrectomy: an Initial Expe-rience. J Gastric Cancer. 2017;17(2):173-179.  https://doi.org/10.5230/jgc.2017.17.e18
  50. Gui D, Gaetano A, Spada PL, Viggiano A, Cassetta E, Albanese A. Botuli-num toxin injected in the gastric wall reduces body weight and food intake in rats. Aliment Pharmacology and Therapeutics. 2000;14(6):829-834.  https://doi.org/10.1046/j.1365-2036.2000.00765.x
  51. Gui D, Mingrone G, Valenza V, Spada PL, Mutignani M, Runfola M, Scar-fone A, Di Mugno M, Panunzi S. Effect of botulinum toxin antral injection an gastric emptying and weight reduction in obese patients: a pilot study. Aliment Pharmacol Ther. 2006;23(5):675-680.  https://doi.org/10.1111/j.1365-2036.2006.02773.x
  52. Pirazzini M, Rossetto O, Eleopra R, Montecucco C. Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology. Pharmacol Rev. 2017;69:200-235.  https://doi.org/10.1124/pr.116.012658
  53. Pero R, Coretti L, Lembo F. Botulinum Toxin A for Controlling Obesity. Toxins. 2016;8(10):281.  https://doi.org/10.3390/toxins8100281
  54. Ahmad SS, Sherpa G, Ahmed AR, Ahmed S. Intragastric Botolinum Toxin-A Injection as a Treatment for Obesity in Comparison to Gastric Balloon. Obes Surg. 2016;26(9). https://doi.org/10.1007/s11695-016-2305-y
  55. Coskun H, Yasin D, Ece D, Mehmet M, Hulya S, Mehmet OD. Effect on Gastric Emptying and Weight Reduction of Botulinum Toxin-A Injection into the Gastric Antral Layer. An Experimental Study in the Obese Rat Model Obesity Surgery. 2005;15:1137-1143. https://doi.org/10.1381/0960892055002275
  56. Mittermair R, Keller Ch, Geible J. İntragastric injection of botulinum toxin a for the treatment of obesity. Obesity Surgery. 2007;17:732-736.  https://doi.org/10.1007/s11695-007-9135-x
  57. Cerfolio RJ, Bryant AS, Canon CL, Dhawan R, Eloubeidi MA. Is botuli-num toxin injection of the pylorus during Ivor-Lewis esophagogastrectomy the optimal drainage strategy? The Journal of Thoracic and cardiovascular Surgery. 2009;137(3):565-572.  https://doi.org/10.1016/j.jtcvs.2008.08.049
  58. Bai Y, Xu MJ, Yang X, Xu C, Gao J, Zou DW, Li ZS. A systemic review on intrapyloric botulinum toxin injection for gastroparesis. Digestion. 2010;81(1):27-34. PMID: 20029206. https://doi.org/10.1159/000235917
  59. Garcia-Compean D, Mendoza-Fuerte E, Martinez JA, Villarreal I, Maldonado H. Endoscopic injection of botulinum toxin in the gastric antrum for the treatment of obesity. Results of a pilot study. Gastroenterol Clin Biol. 2005;29(8-9):789-791.  https://doi.org/10.1016/s0399-8320(05)86349-3
  60. Topazian M, Camilleri M, Mora-Levy JDL, Felicity BE, Amy E Foxx-Oren-stein, Michael J Levy, Nehra V, Nicholas JT. Endoscopic Ultrasound-Guided Gastric Botulinum Toxin Injections in Obese Subjects: A Pilot Study. Obes Surg. 2008;18(4):401-407.  https://doi.org/10.1007/s11695-008-9442-x
  61. James AN, Ryan JP, Parkman HP. İnhibitory effects of boyulinum toxin on pyloric and antral smooth muscle. Am J Physiol Gastrointest Liver Physiol. 2003;285:291-297.  https://doi.org/10.1152/ajpgi.00296.2002
  62. Chan SS. Endoscopic botulinum toxin injection. Benefit and limitation 2014, Society of Gastrointestinal Intervention. 2014;3(1):19-23.  https://doi.org/10.1016/j.gii.2014.03.001
  63. Shahnazarian V, Ramai D, Sarkar A. Endoscopic bariatric therapies for treating obesity: a learning curve for gastroenterologists. Transl Gastroenterol Hepatol. 2019;4:16.  https://doi.org/10.21037/tgh.2019.03.01
  64. Nimeri A, Zaman MB, Maasher A, İbrahim M, Salim E. Endoscopic intra-gastric botulinum toxin injection for obesity leading to total gastroectomy and Roux en Y esophago-jejunostomy. Surgery for Obesity and related diseases. 2016;12(7):116.  https://doi.org/10.1016/j.soard.2016.08.181
  65. David J Bjorkman Bang CS. Intragastric Botulinum Toxin Injection for Obesity. Gastrointest Endosc. 2015 March 9.  https://doi.org/10.1016/j.gie.2014.12.025
  66. Torralvo S, Hernandez V, Tapia MJ, Fernandez A, Olveira G. Intragastric in-jection of botulinum toxin. A real alternative for obesity treatment? A systemic review. Nutricion hospitalaria. 2017;34(5):1482-1488. https://doi.org/10.20960/nh.1220
  67. Elshah H, El-Ejji K, Taheri S. The role of endoscopic Intra-gastric botulinum toxin-A for obesity treatment. Obesity surgery. 2017;9:2471-2478. PMID: 28685363. https://doi.org/10.1007/s11695-017-2806-3
  68. Murizio O, Enrico M, Francesco M, Caterina N, Alessandra V, Cristina B, Fabio C, Diego F, Claudio M. Botulinum neurotoxin-A does not spread to distant muscules after intragastric injection: a double — blind single-fiber electromyography study. Muscle Nerve. 2011;43(3):452-453.  https://doi.org/10.1002/mus.21662
  69. Ferhatoglu MF, Kartal A, Filiz AU, Kebudi A. The positive effects of a calo-rie-restricting high-protein diet combined with intragastric botulinum toxin type A application among morbidly obese patients: a prospective, observational analysis of eighty-seven grade 2 obese patients. Obes Surg. 2020;30(9):3472-3479. https://doi.org/10.1007/s11695-020-04597-y
  70. Garcia-Compean D, Garza HM. Intragastric injection of botulinum toxin for the treatment of obesity. Where are we? World J Gastroenterol. 2008;14(12):1805-1809. https://doi.org/10.3748/wjg.14.1805
  71. Albani G, Petroni ML, Mauro A, Liuzzi A, Lezzi G, Verti B, Marzullo P, Cattani L. Safety and efficacy of therapy with botulinum toxin in obesity: A pilot study. J Gastroenterol. 2005;40:833-835.  https://doi.org/10.1007/s00535-005-1669-x
  72. Junior AC, Savassi-Rocha PR, Coelho LGV, Sposito MM, Albuquerque W, Diniz M. Botulinum A toxin injected into the gastric wall for the treatment of Class III obesity. A pilot Study Obesity Surgery. 2006;16(3):335-343.  https://doi.org/10.1381/096089206776116408
  73. Foschi D, Corsi F, Lazzaroni M, Sangaletti O, Riva P, La Tartara G, Bevilac-qua M, Osio M, Alciati A, Bianchi PG, Trabucchi E. Treatment of morbid obesity by intraparietogastric administration of botulinum toxin: a randomized, double-blind, controlled study. International Journal of Obesity (lond). 2007;31(4):707-712.  https://doi.org/10.1038/sj.ijo.0803451
  74. Li L, Liu QS, Liu WH, Yang YS, Peng LH, Li LY, Meng JY, Wang XD, Ke M. Treatment of obesity by endoscopic gastric intramural infection of botulinum toxin-A: a randomized clinical trial. Hepatogastroenterology. 2012;59(2003-2007). https://doi.org/10.5754/hge11755
  75. Topazian M, Camilleri M, Enders FT, Jonathan EC, Ferga CG, Michael JL, Elizabeth R, Vandana N, Ross AD, Maria L Collazo-Clavell, Nicholas JT, Mat-thew MC. Gastric Antral Injections of Botulinum Toxin Delay Gastric Emptying but Do Not Reduce Body Weight. Clinical Gastroenterology and Hepatology. 2013;11(2):145-150.e1.  https://doi.org/10.1016/j.cgh.2012.09.029
  76. De Moura EG, Bustamante FA, Bernardo WM. Reviewing the reviewers: critical appraisal of «Effect of intragastric injection of botulinum toxin A for the treatment of Obesity: a meta-analysis and meta-regression». Gastrointest Endosc. 2016;83(2):478.  https://doi.org/10.1016/j.gie.2015.08.029
  77. Chang SB, Gwang HB, In SS, Jin BK, Ki TS, Jai HY, Yeon SK, Dong JK. Effect of intragastric injection of botulinum toxin A for the treatment of obesity: a meta-analysis and meta-regression. Gastrointestinal Endoscopy. 2015;81(5):1141-1149. https://doi.org/10.1016/j.gie.2014.12.025
  78. Bustamante F, Brunaldi VO, Bernardo WM, de Moura DTH, de Moura ETH, Galvao M, Santo MA, de Moura EGH. Obesity treatment with botulinum toxin —A is not effective: a systemic review and meta-analysis. Obesity surgery. 2017;27(10):2716-2723. PMID: 28812212. https://doi.org/10.1007/s11695-017-2857-5
  79. Bang CS, Baik GH, Suk KT, Yoon JH, Kim JB, Kim DJ. Effect of intragast-ric injection of botulinum toxin A for the treatment of obesity: A meta-analysis and meta-regression. Gastrointestinal Endoscopy. 2015;81(5):1141-1149. https://doi.org/10.1016/S0016-5085(15)32260-5
  80. Sanchez Torralvo FJ, Valdes Hernandez S, Taria MJ, Abuin Fernandez J, Olveira G. İntragastric injection of botulinum toxin. A real alternative for obesity treatment? A systematic review/ nutrition. Hospitalaria. 2017;34(5):1482-1488. https://doi.org/10.20960/nh.1220
  81. Park JS, Zheng HM, Kim JM, Kim CS, Jeong S, Lee DH. The effect of intragasttic administration of botulinum toxin type A in reducing adiposity in a rat model of obesity using micro-CT and histological examinations. Gutliver. 2017;15;11(6):798-806.  https://doi.org/10.5009/gnl16557
  82. Badurdeen DS, Fayad L, Kalloo AN, Kumbhari V. The forgotten fundus-res-ponse to-obsity treatment with botilinum toxin-A is not effective: a systematic review and meta-analysis. Obes Surg. 2018;28(1):262-263.  https://doi.org/10.1007/s11695-017-3003-0
  83. De Moura E, Ribeiro I, Frazao M, Mestieri LH, De Moura DT, Dal Bo CM, Brunaldi VO, De Moura ET, et al. EUS-guided intragastric injection of botuli-num toxin A in the preoperative treatment of super-obese patients: a randomized clinical trial. Obest Surgery. 2019;29(1):32-39.  https://doi.org/10.1007/s11695-018-3470-y
  84. Ribeiro IB, de Moura DTH, de Moura EGH. Response to letter to the editor re: «EUS-guided intragastric injection of botulinum toxin-A in the preoperative treatment of super-obese patients: a randomized clinical triiiial». Obes Surg. 2019;29(3):1016-1017. https://doi.org/10.1007/s11695-018-03665-8
  85. Gameel A, Bahgat M, Seif S, Habeeb M, El-Ghany MA, Altonbary A, et al. Evaluation of endoscopic ultrasound guided gastric botulinum toxin injections in the treatment of obesty. The Egyptian Journal of Internal Medicine. 2020;32(32):29.  https://doi.org/10.1186/s43162-020-00027-8
  86. Chang PC, Jhou HJ, Chen PH, Huang CK, Chiang HH, Chen KH, Chang TW. Intragastric botulinum toxin A injection ls an effective obesty therapy for patients with BMI >40kg/m2: a systematic review and meta-analysis. Obes Surg. 2020;30(10):4081-4090. https://doi.org/10.1007/s11695-020-04842-4
  87. Kaya B, Bulut NE, Fersahoglu M. Is intragastric botulinum toxin-A injection effective in Obesity treatment? Surg Res Pract. 2020:2419491. https://doi.org/10.1155/2020/2419491
  88. Stimac D, Klobucar Majanovic S, Belancic A. Endoscopic treatment of Obesity: from past to future. Dig Dis. 2020;38:150-162.  https://doi.org/10.1159/000505394
  89. Kasapoglu B, Yozgat A, Kekilli M. Intragastric botox injection barely to the Antrum vs. Diet: Lokman Hekim Health Sciences. 2021;1(1):9-13.  https://doi.org/10.14744/lhhs.2021.70005
  90. Kanlioz M, Ekici U. How taking into account the pyloric tonus contributes to treatment success while administering gastric «Botulinum toxin A» for weight loss. Obes Surg. 2020;30(9):3365-3369. https://doi.org/10.1007/s11695-020-04556-7
  91. Torralvo FJS, Pedreno LV, Marin MG, Tapia MJ, Lima F, Fuentes EG, Garcia P, Ruiz JM, Canete AR, et al. Endooscopic intragastric injection of botulinum toxin A in obese patients on bariatric surgery waiting lists: a randomized double-blind study (Intra Tox study). Clinical nutrition. 2021;40(4):1834-1842. https://doi.org/10.1016/j.clnu.2020.10.008
  92. Youssef T, Abdalla E, El-Alfy K, Dawoud I, Morshed M, Farid M. Impact of botulinum neurotoxin pyloric injection during laparoscopic sleeve gastric leak: a clinical randomized study. Obes Surg. 2016:26(3):494-504.  https://doi.org/10.1007/s11695-015-1794-4
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.